Sales & Marketing News | pharmaphorum

News

Roche gets EU okay for chest pain algorithm

Roche has claimed a CE Mark in the EU for an AI algorithm that can help doctors decide whether patients with chest pain are having a heart attack.

News

First drug for rare disease APDS cleared for NHS use

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat APDS, an ultra-rare immunodeficiency disorder.

News

Has trial result burst BMS' Cobenfy bubble?

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

News

Senior FDA resignations gut drug advertising function

Two senior officials at the FDA's drug promotion office have resigned, leading to speculation that a clampdown on some advertising may be on the way.

News

Roche joins the pharma firms planning big US investments

Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports.

News

Tariffs spelled out with Scrabble letters

Tariffs 'could cancel out discounts with biosimilars'

Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit.

Roche gets EU okay for chest pain algorithm

First drug for rare disease APDS cleared for NHS use

Has trial result burst BMS' Cobenfy bubble?

Senior FDA resignations gut drug advertising function

Roche joins the pharma firms planning big US investments

Tariffs 'could cancel out discounts with biosimilars'

Nuvalent buy delivers new cancer approval for GSK

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks